Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 17Carcinoma, Non-Small-Cell Lung 14Ovarian Neoplasms 7Fallopian Tube Neoplasms 7Pancreatic Neoplasms 6Triple Negative Breast Neoplasms 5Lung Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Inflammatory Breast Neoplasms 3Adenocarcinoma of Lung 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Multiple Myeloma 2Melanoma 2Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms, Male 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma Of Esophagus 2Adenocarcinoma 2Turcot syndrome 1Thrombocytosis 1Stages II-III Breast Cancer 1Stage IIIA Lung Non-Small Cell Cancer AJCC v7 1Stage IA Uterine Sarcoma 1Salivary Gland Neoplasms 1Recurrence 1Prostatic Neoplasms 1Primary Myelofibrosis 1

Interventions

Taxes 1Paclitaxel 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Endometrial Adenocarcinoma × Taxes × Clear all
NCT01041027 2023-10-26

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer

Albert Einstein College of Medicine

Phase 2 Terminated
31 enrolled 8 charts
Gynecologic

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡